면역글로불린제제 국가출하승인을 위한 신규 B형간염표면항원항체가시험 유효성 확인 연구
The quality control of plasma-derived medicinal products, including immunoglobulins, is a key element in the assurance of safety and efficacy of the final products. Among the test items, potency assay for anti-hepatitis B surface antigen has been conducted using various types of enzyme immunoassay s...
Saved in:
| Published in | Yaghag-hoi-ji Vol. 68; no. 4; pp. 287 - 293 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | Korean |
| Published |
The Pharmaceutical Society Of Korea
31.08.2024
대한약학회 |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0377-9556 2383-9457 |
| DOI | 10.17480/psk.2024.68.4.287 |
Cover
| Abstract | The quality control of plasma-derived medicinal products, including immunoglobulins, is a key element in the assurance of safety and efficacy of the final products. Among the test items, potency assay for anti-hepatitis B surface antigen has been conducted using various types of enzyme immunoassay systems. This study aimed to evaluate analytical method validation of enzyme-linked immunosorbent assay (ELISA) and electrochemiluminescence immunoassay (ECLIA) with auto-immunoassay analyzer. Two ELISA and one ECLIA kits, which were available domestically, were selected, and assays were validated using the national standard for human hepatitis B immunoglobulin. Specificity results showed a significant difference between matrix and 20 IU/L sample, indicating anti-hepatitis B surface antigen has no interference from matrix. For both intra-laboratory precision (day, analyst, and instrument) and inter-laboratory precision (reproducibility), the relative standard deviations (RSDs) were not more than 10% to the satisfaction of the three participating laboratories, although one ELISA kit showed higher RSD compared to other kits. Based on these results, both the ELISA and ECLIA can be applied for quality control tests performed by not only the manufacturer but also the national control laboratory as part of national lot release. It is expected that the current study will contribute to further strengthening the quality control capabilities for immunoglobulin products in Korea. KCI Citation Count: 0 |
|---|---|
| AbstractList | The quality control of plasma-derived medicinal products, including immunoglobulins, is a key element in the assurance of safety and efficacy of the final products. Among the test items, potency assay for anti-hepatitis B surface antigen has been conducted using various types of enzyme immunoassay systems. This study aimed to evaluate analytical method validation of enzyme-linked immunosorbent assay (ELISA) and electrochemiluminescence immunoassay (ECLIA) with auto-immunoassay analyzer. Two ELISA and one ECLIA kits, which were available domestically, were selected, and assays were validated using the national standard for human hepatitis B immunoglobulin. Specificity results showed a significant difference between matrix and 20 IU/L sample, indicating anti-hepatitis B surface antigen has no interference from matrix. For both intra-laboratory precision (day, analyst, and instrument) and inter-laboratory precision (reproducibility), the relative standard deviations (RSDs) were not more than 10% to the satisfaction of the three participating laboratories, although one ELISA kit showed higher RSD compared to other kits. Based on these results, both the ELISA and ECLIA can be applied for quality control tests performed by not only the manufacturer but also the national control laboratory as part of national lot release. It is expected that the current study will contribute to further strengthening the quality control capabilities for immunoglobulin products in Korea. KCI Citation Count: 0 |
| Author | 김현정(Hyun Jeong Kim) 한기원(Kiwon Han) 성수경(Su Kyoung Seong) 방윤수(Yun Su Bang) 손경희(Kyung Hee Sohn) 최찬웅(Chan Woong Choi) 김영훈(Young Hoon Kim) |
| Author_xml | – sequence: 1 fullname: 성수경(Su Kyoung Seong) – sequence: 2 fullname: 김현정(Hyun Jeong Kim) – sequence: 3 fullname: 방윤수(Yun Su Bang) – sequence: 4 fullname: 손경희(Kyung Hee Sohn) – sequence: 5 fullname: 김영훈(Young Hoon Kim) – sequence: 6 fullname: 한기원(Kiwon Han) – sequence: 7 fullname: 최찬웅(Chan Woong Choi) |
| BackLink | https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003118640$$DAccess content in National Research Foundation of Korea (NRF) |
| BookMark | eNotkD1Lw1AYhS9SwVr7B5yyuAiJ9yO592asxY9CQZDuoU1vpEQaaV106tBB7KJDSNUU6iIKFqK0tYK_KLn5D6ZWeHnPGc55hrMJcm2vLQDYRlBDTOdw76LrahhiXaNc0zXM2RrIY8KJauoGy4E8JIyppmHQDVDsdlsNSChmnBEjD66Tt6kMJvGilzyHyfwmeYnkOMxOiWeTOOrJeZj6Q3n7LUcLOeorMuynfqjIwTj-CpX9dOjHUV8GP-l9mJFSfyKf7pb_c7osD8I0GGadcfr4KvsfSvrgZxxFBlE8e98C6079vCuK_1oAtcODWvlYrZ4cVcqlqupSg6kGE3XbbhLCHMcWzCGZo8QwTaxTwRmCGFPCuS0QNiEWtM6ayKbYbNAmcRAVpAB2V9h2x7Fcu2V59dafnnmW27FKp7WKhSDNlqQsC--swu6V1_Cshue5tmhfio6lQwQhNTnO5kXkF71ol6Q |
| ContentType | Journal Article |
| Copyright | COPYRIGHT(C) KYOBO BOOK CENTRE ALL RIGHTS RESERVED |
| Copyright_xml | – notice: COPYRIGHT(C) KYOBO BOOK CENTRE ALL RIGHTS RESERVED |
| DBID | P5Y SSSTE ACYCR |
| DOI | 10.17480/psk.2024.68.4.287 |
| DatabaseName | 교보문고 스콜라 Scholar Scholar(스콜라) Korean Citation Index |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| DocumentTitleAlternate | Analytical Method Validation of Antibody to Hepatitis B Surface Antigen Assay for Immunoglobulin Products in National Lot Release |
| EISSN | 2383-9457 |
| EndPage | 293 |
| ExternalDocumentID | oai_kci_go_kr_ARTI_10617467 4010069822871 |
| GroupedDBID | 123 9ZL ALMA_UNASSIGNED_HOLDINGS P2P P5Y SSSTE ACYCR |
| ID | FETCH-LOGICAL-k657-57eaccd337ffce7f333763599246e8710226388ce12902e6a7d1c629b6d3f16e3 |
| ISSN | 0377-9556 |
| IngestDate | Fri Sep 27 04:43:39 EDT 2024 Tue Feb 18 15:18:46 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | Immunoglobulins Potency assay National lot release Analytical method validation |
| Language | Korean |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-k657-57eaccd337ffce7f333763599246e8710226388ce12902e6a7d1c629b6d3f16e3 |
| PageCount | 7 |
| ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_10617467 kyobo_bookcenter_4010069822871 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-08-31 |
| PublicationDateYYYYMMDD | 2024-08-31 |
| PublicationDate_xml | – month: 08 year: 2024 text: 2024-08-31 day: 31 |
| PublicationDecade | 2020 |
| PublicationTitle | Yaghag-hoi-ji |
| PublicationYear | 2024 |
| Publisher | The Pharmaceutical Society Of Korea 대한약학회 |
| Publisher_xml | – name: 대한약학회 – name: The Pharmaceutical Society Of Korea |
| SSID | ssib036278735 ssj0000615188 ssib051116396 ssib044765145 ssib001106857 |
| Score | 2.2811089 |
| Snippet | The quality control of plasma-derived medicinal products, including immunoglobulins, is a key element in the assurance of safety and efficacy of the final... |
| SourceID | nrf kyobo |
| SourceType | Open Website Publisher |
| StartPage | 287 |
| SubjectTerms | 약학 |
| TableOfContents | 서 론(Introduction) 방 법(Methods) 결과 및 고찰(Results and Discussion) 결 론(Conclusion) 감사의말씀(Acknowledgment) Conflict of Interest References |
| Title | 면역글로불린제제 국가출하승인을 위한 신규 B형간염표면항원항체가시험 유효성 확인 연구 |
| URI | https://scholar.kyobobook.co.kr/article/detail/4010069822871 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003118640 |
| Volume | 68 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | 약 학 회 지, 2024, 68(4), , pp.287-293 |
| journalDatabaseRights | – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2383-9457 dateEnd: 99991231 omitProxy: true ssIdentifier: ssib044765145 issn: 0377-9556 databaseCode: M~E dateStart: 20120101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3LbtNA0CrlwgXxFM_KErgX18Hxc_doJ0GhVaFSg9SeosSxmxIpRmlzSA-ohxwQvcAhSoFUKhcEEpUCakuR-KLUuXJmZm03DkXiIUXOanbnsbNez8w-Oe5uugRmUSvrEphuXdIcg0plx1UlqlbKnkkJ9dgu1_mHRv6xNrukL02c-ZFYtdRcL6ecjd_uK_mfVgUYtCvukv2Hlj0hCgBIQ_vCE1oYnn_VxkLOFiwq2JqQywjUFKyskLMEm-DyBcxKCzSDCdsQCGEQQ7BlLGzJLCtKiAxNj_Flhp9BNCyUFaguUIIQArmUMcsimzBBNJGlIFuLS2cYiNhIH0maCLJZLsECEZtYcDtkE8sb1YmRQpmgjC1QeQxiK6xMQlzgFokL3EgskxWiWYIV1kAT7LTIQJQJEtVFjCWRY11kkn77cmmlWlqRqv6q9GQ1fklP6LEEYTqymGBZ8NsXm-JcC7-l8D1m657pCI-pkciRPkI1YEvogJdvNeviLKKI7KrrBJqN4lk0rpk24quQZcAClnbpF1ZQwmC6iyVDnlmoHuDMtVC8vOuKi361HqNFY0CKFg9qR70WvygL1bEpkHjN7yNPnPMh_EiYFZVN2ofHucc20CCJvq4lDVrkDoW-kRLeZnnK7JoaW6j6dK2WQvFSBklpqRPUsePMIZ7H07HBLyV49MNZBawxXrky_yw3cuPTskFGs_HgY4FZGbn1mmYaemI2HGIGiCqiYyNDDyyN5wyyCcSostF-ORT03ikxITCttfyyD_5lveEl_MvCBe58FBjyVtjLL3ITNf8SNx3puzXDF0YbJddm-Gl-YXTmfOsyt3H8cT_o7g2ONo_f9Y4Pnx-_7we7Pfjxg4O9QX8zOOwNO9vBi2_BzlGw0-aDXnvY6fHB1u7ga4-3h9udQb8ddL8PX_WA0rCzF7x9ic8v-4i81Rt2twFnd_jmQ9D-zA9fd4AOH3T7g4NPV7jC_Vwhk5eia1WkmqGbkm6Cr-VUVNX0PMc1PVVFH0OnVNEMl2DAoYBNJo6LI9SKa5TMStoxFFo2KqqXNlz1KjdZ9-vuNY53ZSAkV3QCPq3mejKtpIlSBool1_Ec2bzOTTG9FnHAABebu43iWPtf5-6Awos1Z7WIx9zj_4pfrDWKEMw_KOJoFd6GdONPZG5y50a94hY3ud5ourchVlgvT7EX6ye-PvXq |
| linkProvider | ISSN International Centre |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%EB%A9%B4%EC%97%AD%EA%B8%80%EB%A1%9C%EB%B6%88%EB%A6%B0%EC%A0%9C%EC%A0%9C+%EA%B5%AD%EA%B0%80%EC%B6%9C%ED%95%98%EC%8A%B9%EC%9D%B8%EC%9D%84+%EC%9C%84%ED%95%9C+%EC%8B%A0%EA%B7%9C+B%ED%98%95%EA%B0%84%EC%97%BC%ED%91%9C%EB%A9%B4%ED%95%AD%EC%9B%90%ED%95%AD%EC%B2%B4%EA%B0%80%EC%8B%9C%ED%97%98+%EC%9C%A0%ED%9A%A8%EC%84%B1+%ED%99%95%EC%9D%B8+%EC%97%B0%EA%B5%AC&rft.jtitle=Yaghag-hoi-ji&rft.au=%EC%84%B1%EC%88%98%EA%B2%BD%28Su+Kyoung+Seong%29&rft.au=%EA%B9%80%ED%98%84%EC%A0%95%28Hyun+Jeong+Kim%29&rft.au=%EB%B0%A9%EC%9C%A4%EC%88%98%28Yun+Su+Bang%29&rft.au=%EC%86%90%EA%B2%BD%ED%9D%AC%28Kyung+Hee+Sohn%29&rft.date=2024-08-31&rft.pub=The+Pharmaceutical+Society+Of+Korea&rft.issn=0377-9556&rft.volume=68&rft.issue=4&rft.spage=287&rft.epage=293&rft_id=info:doi/10.17480%2Fpsk.2024.68.4.287&rft.externalDocID=4010069822871 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0377-9556&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0377-9556&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0377-9556&client=summon |